Sofia, Bulgaria, June 11, 2025 – According to the requirements of art. 17 of the Regulation (EU) No 596/2014 of the European Parliament and of the Council, “Sopharma” AD (SFA: Bulgarian Stock Exchange, SPH: Warsaw Stock Exchange) notifies that on June 10, 2025 the Company sold 21 413 (twenty-one thousand four hundred thirteen) repurchased own shares representing 0.01% of the share capital of the Company, at a total value of BGN 138 406.16 on the Bulgarian Stock Exchange, the average price per share was BGN 6.46.

Sofia, Bulgaria, June 10, 2025 – According to the requirements of art. 17 of the Regulation (EU) No 596/2014 of the European Parliament and of the Council, “Sopharma” AD (SFA: Bulgarian Stock Exchange, SPH: Warsaw Stock Exchange) notifies that on June 9, 2025 the Company sold 260 193 (two hundred sixty thousand one hundred ninety-three) repurchased own shares representing 0.14% of the share capital of the Company, at a total value of BGN 1 678 700.92 on the Bulgarian Stock Exchange, the average price per share was BGN 6.45.

Sofia, Bulgaria, June 9, 2025 – According to the requirements of art. 17 of the Regulation (EU) No 596/2014 of the European Parliament and of the Council, “Sopharma” AD (SFA: Bulgarian Stock Exchange, SPH: Warsaw Stock Exchange) notifies that on June 6, 2025 the Company sold 3 310 (three thousand three hundred and ten) repurchased own shares representing 0.002% of the share capital of the Company, at a total value of BGN 21 581.80 on the Bulgarian Stock Exchange, the average price per share was BGN 6.52.